About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 849349, 4 pages
http://dx.doi.org/10.1155/2013/849349
Clinical Study

Use of a New Ocular Insert versus Conventional Mydriasis in Cataract Surgery

Department of Ophthalmology, Miguel Servet University Hospital, Aragonés Institute of Health Sciences, University of Zaragoza, Isabel la Católica 1-3, 50009 Zaragoza, Spain

Received 13 April 2013; Accepted 19 May 2013

Academic Editor: Marcel N. Menke

Copyright © 2013 C. Torrón et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background. To compare the efficacy and safety of a new ocular insert versus conventional mydriasis in cataract surgery. Methods. We selected 70 patients undergoing cataract surgery. Thirty five patients (Group 1) received instillation of mydriatic drops (tropicamide 1%, phenylephrine 10%, and cyclopentolate 1%) prior to surgery, and 35 patients (Group 2) had a Mydriasert insert (Théa Pharma) (0.28 mg of tropicamide and 5.4 mg of phenylephrine hydrochloride) placed in the inferior fornix. Pupil size before and after surgery, blood pressure, and heart rate were measured. Results. Before surgery, pupil diameter was  mm in Group 1 and in Group 2 ( ). Twenty four hours after surgery, pupil diameter was  mm in Group 1 and in Group 2 ( ). There were no statistically significant differences in blood pressure or heart rate between groups. Conclusions. The effect of the Mydriasert insert was similar to conventional mydriatic agents. Pupil size was restored to normal faster when using the Mydriasert insert compared with conventional mydriatic agents for pupil dilation.